Form 8-K - Current report:
SEC Accession No. 0001104659-22-081598
Filing Date
2022-07-21
Accepted
2022-07-21 16:30:45
Documents
14
Period of Report
2022-07-21
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2221588d1_8k.htm   iXBRL 8-K 29058
2 EXHIBIT 3.1 tm2221588d1_ex3-1.htm EX-3.1 8670
3 EXHIBIT 99.1 tm2221588d1_ex99-1.htm EX-99.1 9914
  Complete submission text file 0001104659-22-081598.txt   228303

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA clrb-20220721.xsd EX-101.SCH 3036
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE clrb-20220721_lab.xml EX-101.LAB 34476
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clrb-20220721_pre.xml EX-101.PRE 22597
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2221588d1_8k_htm.xml XML 3607
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Filer) CIK: 0001279704 (see all company filings)

IRS No.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36598 | Film No.: 221097406
SIC: 2834 Pharmaceutical Preparations